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Abstract
Background: Stress urinary incontinence (SUI) is a common problem. In the Netherlands, yearly
64.000 new patients, of whom 96% are women, consult their general practitioner because of
urinary incontinence. Approximately 7500 urodynamic evaluations and approximately 5000
operations for SUI are performed every year. In all major national and international guidelines from
both gynaecological and urological scientific societies, it is advised to perform urodynamics prior
to invasive treatment for SUI, but neither its effectiveness nor its cost-effectiveness has been
assessed in a randomized setting.
Published: 21 July 2009
BMC Women's Health 2009, 9:22 doi:10.1186/1472-6874-9-22
Received: 24 June 2009
Accepted: 21 July 2009
This article is available from: http://www.biomedcentral.com/1472-6874/9/22
© 2009 van Leijsen et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Women's Health 2009, 9:22 http://www.biomedcentral.com/1472-6874/9/22
Page 2 of 7
(page number not for citation purposes)
The Value of Urodynamics prior to Stress Incontinence Surgery (VUSIS) study evaluates the
positive and negative effects with regard to outcome, as well as the costs of urodynamics, in women
with symptoms of SUI in whom surgical treatment is considered.
Methods/design: A multicentre diagnostic cohort study will be performed with an embedded
randomized controlled trial among women presenting with symptoms of (predominant) SUI.
Urinary incontinence has to be demonstrated on clinical examination and/or voiding diary.
Physiotherapy must have failed and surgical treatment needs to be under consideration.
Patients will be excluded in case of previous incontinence surgery, in case of pelvic organ prolapse
more than 1 centimeter beyond the hymen and/or in case of residual bladder volume of more than
150 milliliter on ultrasound or catheterisation.
Patients with discordant findings between the diagnosis based on urodynamic investigation and the
diagnosis based on their history, clinical examination and/or micturition diary will be randomized
to operative therapy or individually tailored therapy based on all available information.
Patients will be followed for two years after treatment by their attending urologist or gynaecologist,
in combination with the completion of questionnaires.
Six hundred female patients will be recruited for registration from approximately twenty-seven
hospitals in the Netherlands. We aspect that one hundred and two women with discordant findings
will be randomized.
The primary outcome of this study is clinical improvement of incontinence as measured with the
validated Dutch version of the Urinary Distress Inventory (UDI). Secondary outcomes of this study
include costs, cure of incontinence as measured by voiding diary parameters, complications related
to the intervention, re-interventions, and generic quality of life changes.
Trial registration: Clinical Trials NCT00814749.
Background
Stress urinary incontinence (SUI) is a frequently occurring
problem. The Health Council of the Netherlands esti-
mated that yearly 64.000 new patients, of whom 96% are
women, consult their general practitioner because of uri-
nary incontinence [1].
In all major national and international guidelines of pro-
fessional organizations and authorities, it is advised to
perform urodynamics prior to invasive treatment for SUI,
e.g. the guidelines of the Dutch Urological Association,
the Dutch Society of Obstetrics and Gynaecology, Interna-
tional Continence Society and European Association of
Urology[2,3].
Usual care in the Netherlands for urinary incontinence in
the general practitioners setting is an investigation by his-
tory, clinical examination and voiding diary. When there
is no clear indication for urge incontinence or neurologi-
cal disease, the patient will be referred for physiotherapy.
In case there is no improvement the patient will subse-
quently be referred to the gynaecologist or urologist [4].
Patient history and clinical examination are important
aspects of the assessment of patients that suffer from stress
urinary incontinence. Patient history is quantified by
using parameters based on validated questionnaires and a
voiding diary for 1 to 2 days. The most common surgical
therapy for SUI is the midurethral sling procedure of
which the tension free vaginal tape (TVT) was first intro-
duced. These slings have an average success rate of 90%
[5].
Urodynamics do not generate major morbidity but are
generally considered as unpleasant by the patients, and
inhere a risk of urinary tract infections as high as 20% [6].
Urodynamics try to enhance the understanding of lower
urinary tract functioning and reveal the underlying
pathology that cause patients complaints. It is an exten-
sion of patient history and physical examination in an
unphysiological setting.
The assumption is that the urodynamic setting is capable
of making a distinction between several pathophysiologi-
cal mechanisms causing the same micturition symptoms.
If this holds true, the outcome of the available treatment
options derived from the urodynamic based diagnosis
would be better than treatment based on diagnosis made
without urodynamics. However, the urodynamic investi-
gations that differentiate between several types of SUI and
specify for the type of operation, lack validation and pre-
dictive value in individual cases [7].BMC Women's Health 2009, 9:22 http://www.biomedcentral.com/1472-6874/9/22
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Moreover, since the introduction of easy to administer
midurethral polypropylene slings, a simplified reasoning
has found ground that states that every type of SUI is
treated in the same way and therefore no urodynamic
investigation would be needed.
The value of urodynamics has never been the specific sub-
ject of a randomized controlled trial [8]. Several studies
have evaluated the value of urodynamics indirectly.
A retrospective cohort study on TVT has concluded that
urodynamics do not have a predictive value on outcome
after midurethral sling surgery [9]. In a randomized con-
trolled trial on Burch compared with pubovaginal sling
procedure, the predictive value of urodynamics was eval-
uated. Findings on urodynamic investigation did not
seem to predict stress continence outcome [10].
The subjective and objective outcome of surgical interven-
tion with or without preoperative urodynamic investiga-
tion has not been compared, with the exception of one
retrospective study on colposuspension and one cohort
study on TVT [11,12]. In these two studies no differences
were found between the groups with and without urody-
namics.
The strong conclusion from the Cochrane Review on the
value of urodynamics was that a randomized trial is
needed [13].
Thus, the role of urodynamics in the objectivation of SUI
in women is nowadays questionable and very much
under debate. In 25–30% of the women the symptom of
SUI is not demonstrable probably due to the artificial sit-
uation during the investigation [5].
If urodynamics are not needed to diagnose types of SUI,
this could be to prevent complications of surgery such as
an overactive bladder. However in almost half of the
patients with overactive bladder symptoms, there are no
abnormal detrusor contractions visible on urodynamics
[14]. On the other hand detrusor contractions during uro-
dynamics that are regarded as the proof for overactive
bladder complaints, can be seen in 20% of women with-
out symptoms of an overactive bladder [15]. It is therefore
questionable, whether it can predict the therapeutic effect
as well as the risk of complications, like de novo urgency
or aggravation of urgency and urinary retention [7,8].
The introduction of minimally invasive techniques for
SUI therapy, such as the midurethral tension free tape pro-
cedure, has led to an enormous increase in the number of
operations in the Netherlands. In 1999, 1,600 operations
were performed. This number has increased to over 4,000
in 2003 and is expected to be 5,000 by today [16].
Economic relevance
We estimate that two thirds of all women with symptoms
of SUI who had urodynamics will proceed to surgery and
one third will be given another non-surgical intervention
which is usually medication. From this calculation it
appears that for this indication urodynamics are per-
formed approximately 7500 times per year in the Nether-
lands.
At expected costs of about 300 euro per test, urodynamics
stand for 2.25 million euro health insurance charges.
In case urodynamics would be omitted, costs of possible
extra complications are foreseen. We estimate a maximum
of 10% additional urgency complaints [17,18]. Antimus-
carinic treatment is available but has a record of only short
time usage in almost all patients, and thus the costs are
limited [19]. The other possible complication is urinary
retention or voiding dysfunction. This occurs in less than
5% of patients after colposuspension, but is less in ten-
sion free midurethral slings and is supposed not to change
with or without urodynamics [20]. This therefore will not
have major financial impact on the outcome. Possible fur-
ther additional costs are costs related to reoperation
(repositioning of the sling estimated at 0.5–1%), and out-
patients' costs.
In conclusion, it is likely that urodynamics do not have a
role in the quality of care for women with SUI and that
urodynamic testing in women with SUI is not cost-effec-
tive.
For this study our hypothesis was that there is no differ-
ence between outcome of surgery and individually tai-
lored therapy in women with a discrepancy between
urodynamic findings and findings from other investiga-
tions, such as history and clinical examination. In case of
confirmation of this hypothesis, urodynamic investiga-
tion in women with predominant SUI could be safely
omitted.
Methods/design
The primary aim of the VUSIS study is to evaluate whether
urodynamic testing is effective in patients with symptoms
of SUI in whom surgical treatment is considered
The VUSIS is a multidisciplinary, multicentre diagnostic
cohort study with a randomized controlled trial (RCT)
embedded. All women with symptoms of predominantly
SUI in whom surgical treatment is considered will
undergo urodynamic investigation. Only women with a
discordant finding compared to history and physical
examination will be randomized. Patients with concord-
ant urodynamics will be registered [see figure 1].BMC Women's Health 2009, 9:22 http://www.biomedcentral.com/1472-6874/9/22
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Summary of trial design Figure 1
Summary of trial design.
Registration of all women with 
predominately stress urinary 
incontinence and indication 
for operation
  RCT 
Midurethral 
sling 
Individual 
treatment
Urodynamics 
Concordant findings
Discordant findings 
Individual 
treatment 
Follow-up 
during 2 
years 
No consent 
Individual 
treatment Questionnaire 
Questionnaire 
Study inclusion and exclusion criteria Figure 2
Study inclusion and exclusion criteria.
Study inclusion and exclusion criteria
Inclusion
•Symptoms of stress urinary incontinence and/or mixed urinary 
incontinence, predominantly stress incontinence 
•Signs of stress urinary incontinence on physical examination or 
voiding diary 
•Patient is a candidate for surgical treatment (as based on history and 
physical examination)
•Patient has attended at least 3 months of pelvic floor exercises
•Patient is capable to fill out bladder diaries and questionnaires and 
understands the Dutch written and spoken language
Exclusion
•Previous incontinence surgery 
•Mixed urinary incontinence, urge component is predominant 
•Pelvic organ prolapse > 1cm beyond the hymen on Valsalva in supine 
position
•Post void urinary residual > 150ml on ultrasound or catheterisation
•Additional pelvic surgery (prolapse and/or hysterectomy) 
•Patient is or wants to become pregnant
•Prior pelvic radiotherapyBMC Women's Health 2009, 9:22 http://www.biomedcentral.com/1472-6874/9/22
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The study has been approved by the institutional review
board of the Radboud University Nijmegen Medical Cen-
tre, in Nijmegen. Ethical approval for this study has been
obtained on 02-10-2008, number 2006/197.
Eligible patients will be identified by gynaecologists and
urologists from participating hospitals in the Netherlands
[see Additional file 1]. All women presenting with SUI
where conservative therapy (i.e. physiotherapy) has failed
and surgical therapy is considered, will be asked for per-
mission of registration in the study. SUI must have been
demonstrated on physical examination and/or micturi-
tion diary. Patients will be excluded in case of previous
incontinence surgery, in case of pelvic organ prolapse 1
centimeter beyond the level of the hymen and/or in case
of residual bladder volume of more than 150 ml on ultra-
sound or catheterization [see figure 2].
In all patients the following items will be recorded at
inclusion:
1. History and clinical examination
2. 48 h-Bladder (voiding and incontinence) diary
3. Validated Quality of Life questionnaires (Short Form
36, Euroqol 5D, Urinary Distress Inventory, Incontinence
Impact Questionnair, Defecatory Distress Inventory)
4. Urinalysis for the detection of urinary tract infection
5. Residual urine measured by ultrasound
All women will undergo urodynamic investigation. Uro-
dynamics will be performed according to International
Continence Society standards and consists of free flow
and measurement of residual, provocative filling cystom-
etry with abdominal leak point pressure measurement,
pressure flow study and a urethral pressure profilometry
in rest and during stress[21]. The outcomes will be
matched with urodynamic findings to assess the poten-
tially useful parts of the urodynamic findings. Postopera-
tive urodynamics is not part of the study.
When the result of the urodynamics does not confirm the
history of SUI, or shows relative contra-indications for
operation, the investigation is called discordant. Whether
a test result is discordant is decided by the attending urol-
ogist or gynaecologist. Figure 3 demonstrates the various
reasons for discordancy.
Women with discordant findings on urodynamics will be
approached to participate in the randomized controlled
part of the study.
After they have given informed consent, the patients with
discordant test results at urodynamics are randomly
assigned to the study or control group. In the study group,
the decision for intervention will be based on history and
clinical examination only, which will be surgical treat-
ment; a midurethral sling. The choice for the kind of pro-
cedure is left to the discretion of the attending doctor. In
the control group the decision for therapy will be based
on history and clinical examination in combination with
the result of the discordant findings on urodynamics. This
includes medical treatment, prolonged physiotherapy,
pessary treatment, but also surgical treatment can be one
of the chosen therapies.
All women with SUI, who present at one of the participat-
ing hospitals, will be referred to a gynaecologist, urologist
or a specifically appointed research nurse for counselling.
Eligible women will receive an information sheet. Once
women with discordant test results have given consent for
the trial, they are randomized through a website, accord-
ing to a computer-generated randomization sequence.
Stratification will be applied for centre. Randomization
will be 1:1 for operative treatment and individual treat-
ment.
Patients in the RCT will be followed up from trial entry
until the end of the study (anticipated average: two years).
Follow-up is composed of the same items as recorded at
inclusion.
After six weeks, six, twelve and twenty-four months
patients will visit their attending gynaecologist or urolo-
gist. Physical examination will be performed and consists
of detection of erosions, stress test for urinary leakage, and
Discordant findings on urodynamic investigation Figure 3
Discordant findings on urodynamic investigation.
Discordant findings on urodynamic
investigation
•Stress incontinence is not demonstrable
•Detrusor overactivity
•Hypocontractility of the bladder
•Poor flow
•Residual urine
•Outflow obstruction
•Small cystometric capacity
•Raised sensibility of the bladder
•Lowered sensibility of the bladder 
•Low level of complianceBMC Women's Health 2009, 9:22 http://www.biomedcentral.com/1472-6874/9/22
Page 6 of 7
(page number not for citation purposes)
measurement of the residual volume. The patients will
complete the questionnaires at all moments of follow-up.
After the intervention additional therapy is possible in
both arms and will be recorded in the Case Record Form.
The cohort group will receive the same questionnaires
once, at one year after the intervention.
Patient outcome measures
The primary outcome of this study is clinical improve-
ment of incontinence as measured with the validated
Dutch version of the UDI.
Secondary outcomes of this study include costs, cure of
incontinence as measured with voiding diaries, complica-
tions such as re-operation or overactive bladder symp-
toms, and quality of life.
The trial results will be incorporated in a diagnostic model
to compare the current strategy (urodynamic evaluation
in all patients) with the alternative strategy (immediate
TVT surgery without urodynamic evaluation).
The study design will enable us to compare the costs and
effects of the following strategies:
I. Immediate midurethral sling without preceding uro-
dynamic evaluation.
II. Urodynamic evaluation in all patients and midure-
thral sling depending on urodynamic evaluation
results.
III. Sequential or probabilistic combinations, based
on the prior probability of the fact that the urody-
namic evaluation will change management.
Sample size considerations
The primary outcome of this study is the improvement of
UDI at 12 months after baseline. The power calculation is
performed using the non-inferiority assumption. The cal-
culation is based on registration of 600 patients in the
cohort study, of whom 200 will have discordant findings.
When approximately 50% of the women give informed
consent for randomization, 102 women with discordant
findings will be randomized (51 to each group). As based
on the non-inferiority assumption, the mean improve-
ment in UDI in both groups is expected to be 35 with
standard deviation of 10. A difference in mean improve-
ment of 5 or less is considered as non-inferior (power
80% using one-sided testing at 0.05).
Economic evaluation
For each patient, utilization of health care services will be
recorded prospectively, using Case Record Forms, includ-
ing urodynamic testing, surgery for SUI, re-operations,
medical treatment for detrusor instability, care for urinary
incontinence, and care for urinary retention. By multiply-
ing these volumes of care with unit cost prices, direct med-
ical costs incurred by SUI during the follow up period will
be calculated for each patient. For unit cost prices,
national guidelines will be used (CVZ, 2004). For costs of
care for urinary incontinence and urinary retention, data
from the literature will be used, converted to 2006 prices.
We incorporated the health related quality of life ques-
tionnaire euroqol 5D in our study to be able to calculate
QALYs (quality-adjusted life-years), which is a measure of
health outcome. A QALY is the change in quality of life
induced by the treatment multiplied by the duration of
the treatment effect and it provides the number of QALYs
gained. QALYs can then be related to medical costs to
arrive at a final common denominator of cost/QALY. This
parameter can be used to compare the cost-effectiveness
of the treatment.
Statistical analysis
Multivariate analysis of covariance with group, centre and
the baseline covariate as independent variables will be
used to estimate differences in improvement of the UDI
after 12 months between the groups with 95% confidence
intervals. As the UDI data are likely to be skewed, data will
be log transformed prior to analysis. Other variables (i.e.
IIQ) will be analyzed similarly.
Time plan for the VUSIS study
Patient recruitment began in January 2009 and is planned
to continue until January 2010. The follow-up has a dura-
tion of 24 months, so will continue until January 2012.
The study is conducted in cooperation with several centers
ensembled in the urogynaecology consortium. Most of
the clinics have disposition over a research nurse, who
attributes in administration and completion of the case
record forms. All data are collected web based.
Knowledge transfer
The outcome of the study will be important for the debate
on the value of urodynamics. In the current international
operative practice for SUI there is a huge increase in the
number of operations. Hence the value of time consum-
ing and costly urodynamic investigations should be very
clear. The study is planned to be a starting point for a doc-
tor's thesis. The results of our study will be submitted to
different national and international scientific societies
such as the International Continence Society and the
International Urogynecologic Association, and is planned
to be published in international scientific journals.
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